Education
About Us
Working with TipRanks
Follow Us
Helius Medical Technologies Inc (HSDT)
:HSDT
HSDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.37 - $1,200.00
Previous CloseN/A
Volume68.49K
Average Volume (3M)1.33M
Market Cap
$592.40M
Enterprise Value-$4.96M
Total Cash (Recent Filing)$6.08M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Aug 07, 2025EPS Estimate
-128.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,299,220
10 Day Avg. Volume1,174,418
30 Day Avg. Volume1,328,218
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue-16.80
Enterprise Value/Gross Profit18.84
Enterprise Value/Ebitda0.24
Forecast
1Y Price Target
$14.00Price Target Upside-12.88% Downside
Rating ConsensusHold
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Clinical ResultsHSDT announced positive results from the PoNS Therapeutic Experience Program, or PoNSTEP, study for people with multiple sclerosis.
Partnerships And ApprovalsUnitedHealthcare has approved reimbursement for the PoNS device, adding a second private payer to provide coverage.
Bears Say
Financial PerformanceHSDT reported lower-than-expected 1Q25 revenue, as adoption of the PoNS device remains inconsistent.
Reimbursement ChallengesThe ongoing reimbursement headwind continues to limit access to key patient populations and suppress near-term growth.
Helius Medical Technologies News
HSDT FAQ
What was Helius Medical Technologies Inc’s price range in the past 12 months?
Helius Medical Technologies Inc lowest stock price was $5.37 and its highest was $1200.00 in the past 12 months.
What is Helius Medical Technologies Inc’s market cap?
Helius Medical Technologies Inc’s market cap is $592.40M.
When is Helius Medical Technologies Inc’s upcoming earnings report date?
Helius Medical Technologies Inc’s upcoming earnings report date is Aug 07, 2025 which is 69 days ago.
How were Helius Medical Technologies Inc’s earnings last quarter?
Helius Medical Technologies Inc released its earnings results on May 08, 2025. The company reported -$8.7 earnings per share for the quarter, the consensus estimate of -$8.7 by $0.
Is Helius Medical Technologies Inc overvalued?
According to Wall Street analysts Helius Medical Technologies Inc’s price is currently Overvalued.
Does Helius Medical Technologies Inc pay dividends?
Helius Medical Technologies Inc does not currently pay dividends.
What is Helius Medical Technologies Inc’s EPS estimate?
Helius Medical Technologies Inc’s EPS estimate is -128.5.
How many shares outstanding does Helius Medical Technologies Inc have?
Helius Medical Technologies Inc has 40,299,220 shares outstanding.
What happened to Helius Medical Technologies Inc’s price movement after its last earnings report?
Helius Medical Technologies Inc reported an EPS of -$8.7 in its last earnings report, expectations of -$8.7. Following the earnings report the stock price went up 0.166%.
Which hedge fund is a major shareholder of Helius Medical Technologies Inc?
Currently, no hedge funds are holding shares in HSDT
Helius Medical Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.00 (-12.88% Downside)
$14.00 (-12.88% Downside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 57.1%
Last 30 Days ▲ 57.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-95.58%
12-Months-Change
Fundamentals
Return on Equity
-344.28%
Trailing 12-Months
Asset Growth
-10.77%
Trailing 12-Months
Company Description
Helius Medical Technologies Inc
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
HSDT Stock 12 Month Forecast
Average Price Target
$14.00
▼(-12.88% Downside)
Technical Analysis
Ownership Overview
36.10%
Insiders
3.10% Mutual Funds
<0.01% Other Institutional Investors
63.90% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---